Approvals/TGA/MSN CABAZITAXEL cabazitaxel 60 mg/1.5 mL concentrated injection vial and diluent vial

Approved

STANDARD

MSN CABAZITAXEL cabazitaxel 60 mg/1.5 mL concentrated injection vial and diluent vial

Reach Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 43ffa1ffb62a2669
Product Name: MSN CABAZITAXEL cabazitaxel 60 mg/1.5 mL concentrated injection vial and diluent vial
Artg Id: 316240
Artg Name: MSN CABAZITAXEL cabazitaxel 60 mg/1.5 mL concentrated injection vial and diluent vial
Sponsor: Reach Pharmaceuticals Pty Ltd
Company Detail Path: /organization/reach-pharmaceuticals-pty-ltd
Artg Date: 2020-08-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/40ae8a8d10e184e355fb41c8ead68a78.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/954829c494c6786b2b3c3dba60c902f5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

43ffa1ffb62a2669

Type

Standard